R&D Cuts Curb Brain-Drug Pipeline

WSJ – As drug companies shake up their research and development operations, the industry risks narrowing its focus to the most profitable areas, raising the prospect that some fields of medicine may be neglected, experts say. Chief among these is neuroscience—research into disorders of the brain. Read article

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>